SMTL ID : 3jus.1 (1 other biounit)

Crystal structure of human lanosterol 14alpha-demethylase (CYP51) in complex with econazole

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-dimer

Ligands

2 x GLC- GLC- GLC- GLC- GLC- GLC- GLC: Cycloheptakis-(1-4)-(alpha-D-glucopyranose)(Non-covalent)

GLC-GLC-GLC-GLC-GLC-GLC-GLC.1: 11 residues within 4Å: Chain A: S.12, P.13, P.14, Y.15, I.16, F.17, S.18, P.19, Y.44 Chain B: Y.430, N.445 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.18 GLC-GLC-GLC-GLC-GLC-GLC-GLC.2: 10 residues within 4Å: Chain A: Y.430, N.445 Chain B: P.13, P.14, Y.15, I.16, F.17, S.18, P.19, Y.44 No protein-ligand interaction detected (PLIP)

2 x ECL: 1-[(2R)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole(Non-covalent)

ECL.3: 13 residues within 4Å: Chain A: Y.83, L.86, T.87, F.91, Y.97, F.186, G.259, L.260, A.263, T.267, I.329 Ligands: HEM.4, ECN.5 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Y.83, A:F.91, A:F.186, A:A.263 ECL.6: 12 residues within 4Å: Chain B: Y.83, L.86, T.87, F.91, Y.97, G.259, L.260, A.263, T.267, I.329 Ligands: HEM.7, ECN.8 3 PLIP interactions: 3 interactions with chain B Hydrophobic interactions: B:F.91, B:A.263 pi-Stacking: B:Y.83

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.4: 27 residues within 4Å: Chain A: Y.83, Y.97, F.104, K.108, L.115, L.260, A.263, G.264, T.267, T.271, L.323, P.328, I.329, M.332, R.334, P.393, F.394, G.395, H.399, R.400, C.401, I.402, G.403, F.406, A.407 Ligands: ECL.3, ECN.5 18 PLIP interactions: 18 interactions with chain A, Hydrophobic interactions: A:F.104, A:L.115, A:L.260, A:A.263, A:L.323, A:P.328, A:I.329, A:F.394, A:I.402, A:F.406, A:A.407 Hydrogen bonds: A:Y.83, A:Y.97, A:H.399 Salt bridges: A:K.108, A:R.334, A:H.399 Metal complexes: A:C.401 HEM.7: 25 residues within 4Å: Chain B: Y.83, Y.97, F.104, K.108, L.260, A.263, G.264, T.267, L.323, P.328, I.329, M.332, R.334, P.393, F.394, G.395, H.399, R.400, C.401, I.402, G.403, F.406, A.407 Ligands: ECL.6, ECN.8 16 PLIP interactions: 16 interactions with chain B, Hydrophobic interactions: B:F.104, B:L.260, B:L.323, B:P.328, B:I.329, B:F.394, B:I.402, B:F.406, B:A.407 Hydrogen bonds: B:Y.97, B:Y.97, B:H.399 Salt bridges: B:K.108, B:R.334, B:H.399 Metal complexes: B:C.401

2 x ECN: 1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE(Non-covalent)

ECN.5: 12 residues within 4Å: Chain A: Y.83, L.86, T.87, F.91, Y.97, F.186, G.259, A.263, T.267, I.329 Ligands: ECL.3, HEM.4 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:F.91, A:F.186, A:A.263 Hydrogen bonds: A:Y.97 pi-Stacking: A:Y.83 ECN.8: 12 residues within 4Å: Chain B: Y.83, L.86, T.87, Y.97, F.104, F.186, G.259, A.263, T.267, I.329 Ligands: ECL.6, HEM.7 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:F.104, B:F.186, B:A.263 pi-Stacking: B:Y.83

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Strushkevich, N. et al., Structural basis of human CYP51 inhibition by antifungal azoles. J. Mol. Biol. (2010)

Release Date

2010-03-02

Peptides

Lanosterol 14-alpha demethylase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Lanosterol 14-alpha demethylase

Related Entries With Identical Sequence